Keywords: فیبرها; Antiplatelet therapy; aspirin; fibrates; fibrinolytics; hyperlipidaemia; lipid disorders; MRCP; nicotinic acid; omega-3 fatty acids; statins;
مقالات ISI فیبرها (ترجمه نشده)
مقالات زیر هنوز به فارسی ترجمه نشده اند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
Keywords: فیبرها; Secondary prevention; Fibrates; Review; Prevención secundaria; Fibratos; Revisión;
Keywords: فیبرها; Prevención secundaria; Fibratos; Revisión; Secondary prevention; Fibrates; Review;
Keywords: فیبرها; Fibrates; Glucose; Insulin; Insulin resistance; Meta-analysis;
Keywords: فیبرها; HDL-C; Ezetimibe; Fibrates; Cardiovascular disease;
Keywords: فیبرها; CVD; cardio vascular disease; NCD; non-nommunicable disease; MONICA; multinational MONItoring of trends and determinants in CArdiovascular disease; CHD; coronary heart disease; ACS; acute coronary syndrome; TG; triglyceride; LDL-C; low density lipoprotein
Keywords: فیبرها; Dyslipidemia; Cardiovascular risk; Statins; Fibrates; Consensus statement; LDLc goal;
Keywords: فیبرها; Dyslipidemia; Lipoproteins; Cholesterol; Triglycerides; Statins; Fibrates; Niacin; Bile acids; Natural products;
Keywords: فیبرها; Dislipidemia aterogénica; Fibratos; Fenofibrato; Triglicéridos; Riesgo cardiovascular; Atherogenic dyslipidemia; Fibrates; Fenofibrate; Triglycerides; Cardiovascular risk;
Keywords: فیبرها; LDL; HDL; Statins; Fibrates; Cardiovascular;
Keywords: فیبرها; Dyslipidemia; Cardiovascular risk; Statins; Fibrates; Consensus statement; LDLc goal;
Keywords: فیبرها; ACS; acute coronary syndrome; ACC; American College of Cardiology; AHA; American Heart Association; BMI; body mass index; CVD; cardiovascular disease; CI; confidence interval; CRP; C-reactive protein; Fib; fibrinogen; HDL-C; high-density lipoprotein chole
Keywords: فیبرها; Cardiovascular disease; Cardiovascular events; Fibrates; Hypertriglyceridemia; Lipid-altering drug therapy; Niacin; Omega-3 fatty acids; Triglyceride-lowering therapy;
Keywords: فیبرها; Statins; Fibrates; Lipid profiles; Adverse events; Dyslipidemia
Keywords: فیبرها; Fibrates; Hypertriglyceridemia; Long-chain omega-3 fatty acids; Niacin; Statins; Triglycerides;
Keywords: فیبرها; Antiplatelet therapy; aspirin; fibrates; fibrinolytics; hyperlipidaemia; lipid disorders; nicotinic acid; omega-3 fatty acids; statins
Keywords: فیبرها; Fibrates; Fenofibrate; Catalase; Alcoholism; Treatment; Peroxisome proliferator-activated receptor;
Keywords: فیبرها; Lipids; Cholesterol; Statin; Niacin; Fibrates; Ezetimibe; Omega-3 fatty acids; Cardiovascular risk;
Keywords: فیبرها; Fibrates; Polyunsaturated fatty acids; Statins; Heart failure;
Keywords: فیبرها; dyslipidemia; chronic liver disease; chronic kidney disease; end stage renal disease; statins; fibrates; ezetimibe
Keywords: فیبرها; type 2 diabetes; type 1 diabetes; dyslipidemia; cardiovascular disease; lifestyle intervention; statins; fibrates
Keywords: فیبرها; Fibrates; Nicotinic acid; Omega-3 fatty acids; PPARα and PPARα/γ agonists; Squalene synthase inhibitors; Statins; Triglyceride-lowering agents
Keywords: فیبرها; High-density lipoprotein; Apolipoprotein A-I; High-density lipoprotein particles; Reverse cholesterol transport; Atherosclerosis; Niacin; Fibrates; Cholesteryl ester transfer protein inhibitor;
Keywords: فیبرها; Residual cardiovascular risk; Fibrates; Omega-3 fatty acids; Atherosclerosis; Insulin resistance;
Keywords: فیبرها; Primary biliary cirrhosis; Therapeutics; Ursodeoxycholic acid; Fibrates; 6α-Ethyl-chenodeoxycholic acid;
Ecotoxicity of the lipid-lowering drug bezafibrate on the bioenergetics and lipid metabolism of the diatom Phaeodactylum tricornutum
Keywords: فیبرها; Fibrates; Pharmaceuticals; Marine primary producer; Photochemistry; Fatty acids;
Primary biliary cholangitis: Old and novel therapy
Keywords: فیبرها; Primary biliary cholangitis; Primary biliary cirrhosis; Ursodeoxycholic acid; Obeticholic acid; Fibrates; Budesonide; Rituximab; Ustekinumab; Treatment;
Fibrates in primary prevention of cardiovascular disease. Comments on the results of a systematic review of the Cochrane Collaboration
Keywords: فیبرها; Primary prevention; Fibrates; Review; Cardiovascular disease; Prevención primaria; Fibratos; Revisión; Enfermedad cardiovascular;
Los fibratos en la prevención primaria de la enfermedad cardiovascular. Comentarios a los resultados de una revisión sistemática de la Colaboración Cochrane
Keywords: فیبرها; Prevención primaria; Fibratos; Revisión; Enfermedad cardiovascular; Primary prevention; Fibrates; Review; Cardiovascular disease;
Efficacy and safety of pemafibrate (K-877), a selective peroxisome proliferator-activated receptor α modulator, in patients with dyslipidemia: Results from a 24-week, randomized, double blind, active-controlled, phase 3 trial
Keywords: فیبرها; Selective PPARα modulator; Pemafibrate; K-877; Triglycerides; Dyslipidemia; Liver dysfunction; Fatty liver; Homocysteine; Renal dysfunction; Fibrates;
A multibiomarker approach highlights effects induced by the human pharmaceutical gemfibrozil to gilthead seabream Sparus aurata
Keywords: فیبرها; Fibrates; Seabream; Behavior; Biomarkers; Oxidative damage;
Analysis of the Cochrane Review: Fibrates for secondary prevention of cardiovascular disease and stroke
Keywords: فیبرها; Fibrates; Cardiovascular events; Stroke; Secondary prevention; Systematic review; Fibratos; Eventos cardiovasculares; Acidente vascular cerebral; Prevenção secundária; Revisão sistemática;
Primary Biliary Cholangitis: advances in management and treatment of the disease
Keywords: فیبرها; Alkaline phosphatase; Budesonide; Fibrates; Obeticholic acid; Ursodeoxycholic acid;
A novel structural class of coumarin-chalcone fibrates as PPARα/γ agonists with potent antioxidant activities: Design, synthesis, biological evaluation and molecular docking studies
Keywords: فیبرها; Fibrates; Coumarin-chalcone; PPARα/γ agonists; Antioxidant activity;
Pharmacologic approaches for the management of patients with moderately elevated triglycerides (150-499 mg/dL)
Keywords: فیبرها; Hypertriglyceridemia; Guidelines; Fibrates; Omega-3 fatty acids; Dyslipidemia;
PPARs and nonalcoholic fatty liver disease
Keywords: فیبرها; Liver; NAFLD; NASH; PPAR; Thiazolidinediones; Fibrates;
JCL roundtable: Managing lipid disorders in young women
Keywords: فیبرها; Hypercholesterolemia; Hypertriglyceridemia; Low-density lipoprotein; Non-HDL-Cholesterol; Young women; Pregnancy; Pancreatitis; Statins; Fibrates; Omega-3 fats;
Synthesis, in vitro evaluation, and molecular modeling investigation of benzenesulfonimide peroxisome proliferator-activated receptors α antagonists
Keywords: فیبرها; PPARs; PPAR antagonist; Transactivation assay; Benzenesulfonimides; CPT1A; Fibrates; Docking; Molecular dynamic
Original researchAcute pancreatitis associated with severe hypertriglyceridaemia; A retrospective cohort study
Keywords: فیبرها; Acute pancreatitis; Amylase; Fibrates; Hypertriglyceridaemia; Lipaemia; Statins;
Enzymatic characterization of ELOVL1, a key enzyme in very long-chain fatty acid synthesis
Keywords: فیبرها; ALDP; adrenoleukodystrophy protein; AMN; adrenomyeloneuropathy; ELOVL; elongation of very long-chain fatty acids; PPAR; peroxisome proliferator-activated receptor; VLCFA; very long-chain fatty acids; Adrenoleukodystrophy; Peroxisome; Substrate-reduction;
Treatment of primary hypertriglyceridemia states – General approach and the role of extracorporeal methods
Keywords: فیبرها; Hypertriglyceridemia; Familial hyperchylomicronemia; Lipoprotein lipase; Lifestyle; Omega3-fatty acids; Fibrates; Lipoprotein apheresis; Plasma exchange; Atherosclerotic disease; Acute pancreatitis; Apolipoprotein CIII inhibitors; Lomitapide; Alipogene ti
Innovative pharmaceutical interventions in cardiovascular disease: Focusing on the contribution of non-HDL-C/LDL-C-lowering versus HDL-C-raisingA systematic review and meta-analysis of relevant preclinical studies and clinical trials
Keywords: فیبرها; Cardiovascular disease; Clinical outcome; Myocardial infarction; LDL-cholesterol; Non-HDL-cholesterol; HDL-cholesterol; Atherosclerosis; Clinical trials; APOE*3Leiden.CETP mice; Mouse; Rabbit; Hamster; Niacin; Fibrates; Glitazones; PPAR agonists; CETP inh
Regulation of mitochondrial fatty acid β-oxidation in human: What can we learn from inborn fatty acid β-oxidation deficiencies?
Keywords: فیبرها; Mitochondrial fatty acid β-oxidation; Inborn enzyme defects; Newborn screening; Pharmacological therapy; PPAR; Fibrates;
Discovery, synthesis and in combo studies of a tetrazole analogue of clofibric acid as a potent hypoglycemic agent
Keywords: فیبرها; Diabetes; 11β-HSD1; Fibrates; Molecular docking
Lymphocyte-suppressing, endothelial-protective and systemic anti-inflammatory effects of metformin in fenofibrate-treated patients with impaired glucose tolerance
Keywords: فیبرها; fibrates; inflammatory cells; low-grade inflammation; metformin; prediabetes
Monocyte-suppressing effect of high-dose metformin in fenofibrate-treated patients with impaired glucose tolerance
Keywords: فیبرها; fibrates; inflammatory cells; low-grade inflammation; metformin; prediabetes
Effect of metformin on selected parameters of hemostasis in fenofibrate-treated patients with impaired glucose tolerance
Keywords: فیبرها; metformin; fibrates; prediabetes; hemostasis; risk factors
11beta-Hydroxysteroid dehydrogenase type 1 inhibitors: novel agents for the treatment of metabolic syndrome and obesity-related disorders?
Keywords: فیبرها; 11β-hydroxysteroid dehydrogenase type 1; Carbenoxolone; Thiazolidinediones; Fibrates; BVT2733; INCB-1373911β-HSD1 and 11β-HSD2, 11β-hydroxysteroid dehydrogenase type 1 and type 2; ACTH, adrenocorticotropic hormone; ASC, adipose stromal cells; ASO, antisen
Synthesis of highly water-soluble fibrate derivatives via BGLation
Keywords: فیبرها; Anti-hyperpemia; Water-solubility; Fibrates; Permiability
Synthesis and structure-activity relationships of fibrate-based analogues inside PPARs
Keywords: فیبرها; PPARs; Transactivation assay; Fibrates; Chalcone; Stilbene; Gene expression;